-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

603. Lymphoid Oncogenesis: Basic: Poster III

Symposia: Lymphoid Oncogenesis: Basic Program: Oral and Poster Abstracts
Type: Poster
Monday, December 12, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Kadriye Nehir Cosgun, PhD1*, Wei Liu2*, Mark E. Robinson, PhD1*, David Fonseca Arce1*, Jennifer VanOudenhove, PhD3*, Alberto Bigogno1*, Richard Flavell, PhD4*, Stephanie Halene, MD2 and Markus Müschen, MD1

1Center of Molecular and Cellular Oncology and Department of Immunobiology, Yale University, New Haven, CT
2Section of Hematology, Department of Internal Medicine and Yale Comprehensive Cancer Center, Yale University School of Medicine, New Haven, CT
3Section of Hematology, Department of Internal Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT
4Department of Immunobiology, Yale University School of Medicine, New Haven, CT

Ethan Whipp, MSc1,2*, Zachary A Hing, MD, PhD3,4, Janek S. Walker, PhD5, Steven Sher6*, Casey B. Cempre, B.S.5*, Fiona Brown, BS7, Claudio Agostinelli, MD8,9*, Stefano A Pileri10,11,12, Katie Williams, MS5*, Larry Beaver, BS5*, Alexander Pan, BS13*, Charles T. Gregory5,14*, Pearlly S. Yan, PhD15*, Peggy Scherle, PhD16, Min Wang17*, Kris Vaddi, PhD16,17,18, Selina Chen-Kiang, PhD19,20,21,22, Jennifer A. Woyach, MD5,7,23, James S. Blachly, MD5,24,25, Lapo Alinari, MD, PhD7, Yiping Yang, MD, PhD26, Robert A. Baiocchi, MD, PhD5,14, Bradley W Blaser, MD, PhD5,27 and Rosa Lapalombella, PhD28,29

1Division of Hematology, Ohio State University, Columbus, OH
2Division of Pharmaceutics & Pharmacology, Ohio State University - College of Pharmacy, Columbus, OH
3Division of Hematology, Department of Internal Medicine, The Ohio State University, Wexner Medical Center, Columbus, OH
4Medical Scientist Training Program, The Ohio State University, Wexner Medical Center, Columbus, OH
5Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
6Division of Hematology, Department of Internal Medicine, THE OHIO STATE UNIVERSITY, COLUMBUS, OH
7Department of Internal Medicine, Division of Hematology, College of Medicine, The Ohio State University, Columbus, OH
8Haematopathology Unit, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, ITA
9Haematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna and Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy
10Hematopathology Division, IEO Istituto Europeo di Oncologia IRCCS, Milano, Italy
11University of Bologna, Milan, Italy
12European Instute of Oncology, Milan, Italy
13The Ohio State University, Columbus, OH
14Comprehensive Cancer Center, The Ohio State University, Columbus, OH
15Genomic Shared Resource, The Ohio State University, Columbus, OH
16Research and Development, Prelude Therapeutics, Wilmington, DE
17Prelude Therapeutics, Wilmington, DE
18Incyte Corporation, Wilmington, DE
19Weil Cornell Medicine, Cornell University, New York, NY
20Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY
21Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY
22Graduate Program in Immunology and Microbial Pathogenesis, Weill Cornell Medicine, New York, NY
23Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH
24Department of Biomedical Informatics, The Ohio State University, Columbus, OH
25Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH
26Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
27The Ohio State University Comprehensive Cancer Center, Division of Hematology, Columbus, OH
28The Ohio State University Comprehensive Cancer Center, Columbus, OH
29Division of Hematology, Department of Medicine, The Ohio State University, Columbus, OH

Luz Yurany Moreno Rueda, Ph.D., M.Sc.1*, Dean Bryant, PhD1*, William J Tapper, PhD2*, Nicky Weston-Bell, PhD, BSc1*, David C Wedge, PhD3*, Naser Ansari-Pour, PhD4* and Surinder S Sahota, PhD1*

1Tumour Immunogenetics Group, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, United Kingdom
2Genetic Epidemiology and Genomic Informatics Group, Human Genetics, Faculty of Medicine, University of Southampton, Southampton, United Kingdom
3Manchester Cancer Research Centre, University of Manchester, Manchester, United Kingdom
4MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom

Triantafyllia Brozou, MD1*, Rabea Wagener, PhD2*, Danielle Brandes3*, Ute Fischer, PhD2* and Arndt Borkhardt, MD4

1Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich-Heine-University and University Hospital Duesseldorf, Duesseldorf, Germany
2Department of Pediatric Oncology, Hematology and Clinical Immunology, Heinrich Heine University, Medical Faculty, Duesseldorf, Germany
3Duesseldorf School of Oncology (DSO), Medical Faculty, Heinrich-Heine University, Duesseldorf, Germany
4Department of Pediatric Oncology, Hematology and Clinical Immunology, Heinrich-Heine University Duesseldorf, Medical Faculty, Duesseldorf, Germany

Gabriela Cristina Segat, MSc1*, Ann Chong Sun1*, Alice C Zhu2*, Marissa Foo1*, Claudia V Barreto Rodriguez1*, Rachel Wong1*, Samuel Gusscott, PhD1*, Martin Hirst, PhD2* and Andrew P. Weng, MD3

1Terry Fox Laboratory, BC Cancer, Vancouver, BC, Canada
2Canada’s Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada
3Terry Fox Laboratory, BC Cancer Agency, Vancouver, BC, Canada

Sakurako Suma, MD1,2*, Manabu Fujisawa, MD, PhD3*, Yoshiaki Abe, MD1*, Yasuhito Suehara, MD, PhD2,3*, Daisuke Kaji, MD, PhD4*, Takeshi Sugio, MD5*, Koji Kato, MD, PhD6, Koichi Akashi, MD, PhD7, Kosei Matsue, MD, PhD8, Naoya Nakamura, MD, PhD9*, Ayako Suzuki, Ph.D.10*, Yutaka Suzuki, Ph.D.11*, Shigeru Chiba, MD, PhD2,3 and Mamiko Sakata-Yanagimoto, MD, PhD2,3,12*

1Department of Hematology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan
2Department of Hematology, University of Tsukuba Hospital, Tsukuba, Japan
3Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
4Department of Hematology, Toranomon Hospital, Tokyo, Japan
5Department of Medicine, Division of Oncology, Stanford University, Stanford, CT
6Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science, Fukuoka, Japan
7Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan
8Department of Hematology/Oncology, Kameda Medical Center, Kamogawa, Japan
9Department of Pathology, Tokai University School of Medicine, Isehara, Japan
10Department of Computational Biology and Medical Sciences, The University of Tokyo, Kashiwa, Japan
11Laboratory of Systems Genomics, Department of Computational Biology and Medical Sciences, The University of Tokyo, Tokyo, Japan
12Division of Advanced Hemato-Oncology, Transborder Medical Research Center, University of Tsukuba, Tsukuba, Japan

Wangisa M.B. Dunuwille, PhD, BVSc.1*, William Casey Wilson, PhD2*, Nancy Issa, MD1*, Won Kyun Koh, PhD1, Wentao Han3* and Grant A Challen, PhD1

1Division of Oncology, Washington University School of Medicine, St. Louis, MO
2Scientific research laboratory, Arch Oncology, St. Louis, MO
3Division of Oncology, Washington University School of Medicine, Saint Louis, MO

Lai N. Chan, PhD1, Mark E. Robinson, PhD1*, Kadriye Nehir Cosgun, PhD1*, Xiaohui Yu1*, Etienne Leveille, MD1, Huimin Geng, PhD2 and Markus Müschen, MD1

1Center of Molecular and Cellular Oncology and Department of Immunobiology, Yale University, New Haven, CT
2Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA

Pauline Schneider1*, Susan T.C.J.M. Arentsen-Peters, BSc1*, Nicholas T. Crump2*, Alastair Smith2*, Rico Hagelaar, MSc1,3*, Fabienne R.S. Adriaanse, MSc1*, Romy S. Bos1*, Kirsten S. Vrenken, PhD1*, Dedeke rockx-Brouwer1*, Ziqin Tang1,3*, Wilbert P. Vermeij1,3*, Anja De Jong4*, Bianca Koopmans, BSc1*, M.Emmy M. Dolman1*, Thomas A. Milne2, Rob Pieters, Prof. MD. PhD1 and Ronald W. Stam, PhD1*

1Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
2MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, NIHR Oxford Biomedical Research Centre Haematology Theme, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom
3Oncode Institute, Utrecht, Netherlands
4Dutch Oncology Group, Utrecht, NLD

Nguyet Minh Hoang, BS1, Yunxia Liu, PhD1* and Lixin Rui, PhD2

1Department of Medicine and Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI
2Department of Medicine and Carbone Cancer Center, University of Wisconsin School of Medicine, Madison, WI

B. Hilda Ye, PhD1, Elaine Chung, PhD1*, Xiaoxin Ren, Ph.D.2*, Kith Pradhan, PhD3*, Yanhua Wang, MD, PhD4*, Advaitha Madireddy, PhD5, Xingxing Zang, PhD6*, Murali Janakiram, MD, MS7, R. Alejandro Sica, MD8 and Amit Verma, MD9

1Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY
2Albert Einstein College of Medicine, Bronx, NY
3Department of Epidemiology & Population Health, Montefiore Medical Center, Bronx, NY
4Department of Pathology, Montefiore Medical Center Center for Cancer Care, Bronx, NY
5Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
6Montefiore Medical Center Center for Cancer Care, Bronx, NY
7Department of Hematology and Medical Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
8Hematology/Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
9Department of Oncology, Montefiore Medical Center/ Albert Einstein College of Medicine, Bronx, NY

Kevin O'Connor, MSc1*, Kensei Kishimoto1*, Irena Kuzma1*, Kelsey Wagner1*, Jonathan Selway1*, Kayleigh M Gallagher, PhD1, Justine E. Roderick, PhD1*, David J. Curtis, MBBS, PhD2, Cedric Tremblay, PhD3* and Michelle A Kelliher, PhD1

1Department of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA
2Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia
3Australian Centre for Blood Diseases, Monash University, Melbourne, Australia

Haopeng Yang, PhD1*, Wenchao Zhang, PhD1*, Vida Ravanmehr2*, Jared Henderson, PhD3*, Qing Deng, PhD3*, Felipe Samaniego, MD4, Fernando Rodrigues-Lima5* and Michael R. Green, PhD6

1Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX
2University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
5University of Paris, Paris, France
6Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Friendswood, TX

Guy Jacques LeClerc, PhD, BSc1*, Helena Gomes Dos Santos, PhD2*, Guangyan Sun, PhD3*, Ramin Shiekhattar, PhD4* and Julio C Barredo, MD1,5,6,7

1Pediatrics, University of Miami Miller School of Medicine, Miami, FL
2Department of Human Genetics, University of Miami Miller School of Medicine, Miami, FL
3Department of Pediatrics, University of Miami Miller School of Medicine, Miami, FL
4Department of Human Genetics, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
5Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
6Medicine, University of Miami Miller School of Medicine, Miami, FL
7Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL

Christoph Weigel, PhD1,2*, Esko Kautto1,2, Elshafa H. Ahmed, DVM, PhD3,4, Yue-Zhong Wu1,2*, Charles T. Gregory1,2*, Ada C. Cleary1,2*, Sarah Y. Schlotter1,2, Eric Brooks, BS1,2*, Mark Lustberg5*, Robert A. Baiocchi, MD, PhD1,2, James S. Blachly, MD1,2,6 and Christopher C. Oakes, PhD2,6,7

1Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
2Comprehensive Cancer Center, The Ohio State University, Columbus, OH
3Department of Internal Medicine, Division of Hematology, College of Medicine, The Ohio State University, Columbus, OH
4Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH
5Division of Infectious Diseases, Yale School of Medicine, New Haven, CT
6Department of Biomedical Informatics, The Ohio State University, Columbus, OH
7Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus

*signifies non-member of ASH